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Background/aim: The emergence of the coronavirus disease 2019 (COVID-19) outbreak has had an enormous emotional impact on
some vulnerable groups, such as people living with human immunodeficiency virus (HIV) (PLHIV). This study was planned with the
aim of assessing the anxiety levels of PLHIV and the sources of their anxiety.
Materials and methods: A web-based questionnaire was sent to PLHIV using the virtual snowball sampling method. The questionnaire
included questions about sociodemographic status, information about HIV infection, and the Beck Anxiety Inventory (BAI).
Additionally, some opinions of the participants about COVID-19 were asked.
Results: A total of 307 respondents, with a median age of 33 years, from 32 different cities, participated in the study. More than half
of the respondents reported the belief that COVID-19 was not sufficiently well-known by the medical community and nearly 45%
believed that they would have more complications if they contracted COVID-19. One-fourth of the participants had anxiety. Having a
preexisting psychiatric disorder, perceiving that they were practicing insufficient preventive measures, not being sure about the presence
of any individuals with COVID-19 in their environment, and living with a household member with a chronic disease were found to be
the risk factors of PLHIV for having anxiety during this pandemic. The BAI scores were correlated with the patient-reported anxiety
levels about the spread of COVID-19 in Turkey, acquiring COVID-19, transmitting COVID-19 to another person, and transmitting
HIV to another person. Among the stated conditions, the most common concern was the spread of COVID-19 all over the country,
while the least common was transmitting HIV to someone else.
Conclusion: The results revealed that a significant proportion of the sample had anxiety, and the findings were essential for developing
evidence-based strategies for decreasing the anxiety of PLHIV, especially for those who had risk factors and to provide them with better
health care during this pandemic or other pandemic-like crises.
Key words: Anxiety, COVID-19, emotional response, HIV, pandemic, uncertainty

1. Introduction
The first case coronavirus disease 2019 (COVID-19)
detected in Turkey was on 10 March 2020, and
approximately 3 months prior to that, the first cases had
been identified in China’s Wuhan-Hubei Province [1].
After being reported by the World Health Organization
that some suspicious cases had been detected in China,
very important control measures were put into place by
the Turkish Government [2,3]. At the beginning of the
outbreak, the frightening news on social media had caused
a panic[4]. After the implementation of a successful control
system over the virus, Turkey is now in the normalization
process. According to official numbers, there were 17,5218
cases and 4778 deaths in Turkey, as of 12 June 2020.

The first presented patient with coinfection of severe
acute respiratory syndrome coronavirus 2 (SARSCoV-2) and human immunodeficiency virus (HIV)
was diagnosed with HIV positivity after acquiring the
coronavirus infection [5]. Other case reports, case series,
and comments followed this publication [6–10]. Altuntaş
Aydın et al. reported 4 cases of PLHIV coinfected with
SARS-CoV-2 from Turkey [11]. Vizcarra et al. found a rate
of coinfection in PLHIV of 1.2%–1.8%, and their results
did not support the previous suggestions that PLHIV
might be protected from worse outcomes [12].
The COVID-19 pandemic has had an enormous
emotional impact on some vulnerable groups, such as
PLHIV [13]. Some reports from China have shown that
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PLHIV were concerned with HIV-specific protective
measures, medication shortages, and the need for
psychosocial support [14,15]. The COVID-19 outbreak
is expected to create extra physical and psychosocial
burden for PLHIV. Taking all of these existing data into
consideration, this study was planned with the aim of
investigating the anxiety levels of PLHIV and define their
needs during the COVID-19 pandemic.
2. Materials and methods
This study was performed in collaboration with the
Infectious Diseases and Clinical Microbiology Department
and Psychiatry Department of Ege University Faculty of
Medicine.
2.1. Participants
The sample consisted of 307 PLHIV. The virtual snowball
sampling method was used. A web-based questionnaire
was first sent to patients who were being followed-up
for HIV infection at the Infectious Diseases and Clinical
Microbiology Department of Ege University Hospital.
These patients were asked to send the questionnaire
to other PLHIV who were in their social network. All
responses fulfilling the inclusion criteria were analyzed.
The inclusion criteria comprised 1) having a diagnosis
of HIV infection, 2) being above 18 years of age, and 3)
volunteering to complete the survey.
2.2. Procedure
This study was approved by the Ege University Research
Ethics Committee (4 April 2020; 99166796-050.06.04). A
Google form was designed for data collection regarding
the sociodemographic status, information about HIV
infection, such as the time duration since having been
diagnosed, medication compliance, and knowledge
level about COVID-19. Additionally, the Beck Anxiety
Inventory (BAI), which is a 21-item self-report test that
measures the severity of anxiety, was added [16]. In the
BAI, scores can range from 0 to 63, with higher numbers
suggesting greater degrees of anxiety. The suggested cutoff for clinically significant anxiety on the BAI is 16 [17],
and participants who had a BAI score higher than 16
were determined as having anxiety in the current study.
The Turkish version of the BAI was found to be valid and
reliable [18].
Participation in this study was anonymous. Data were
collected within a period of 1 week, from 6 April 2020 to
13 April 2020, to minimize the influence of rapid changes
during the pandemic. Apart from the BAI, participants
were requested to rate their anxiety level between 1 and
10, for the spread of COVID-19 in Turkey, acquiring
coronavirus, transmitting coronavirus to another person,
and transmitting HIV to another person.

2.3. Statistics
Data analyses were performed using IBM SPSS for
Windows 21.0 (IBM Corp., Armonk, NY, USA). The
Kolmogorov–Smirnov test was used to test normality.
All of the quantitative variables had skewed distribution;
therefore, they were expressed as the median and
minimum–maximum values. Categorical variables were
presented as frequency and percentage. The Mann–
Whitney U or Kruskal–Wallis tests were used to compare
the quantitative data. For comparison of the categorical
variables, the χ² test or Fisher exact test was used. The
Spearman rank test was used to assess correlations between
continuous variables. P < 0.05 was considered statistically
significant. For the multivariate analysis, a backward
stepwise logistic regression procedure was performed. The
Chronbach alpha test was used to measure the internal
consistency reliability of the BAI in the studied sample.
3. Results
3.1. Sociodemographic variables
Among the 307 respondents, 289 (94.1%) were male. The
median age was 33 (between 18 and 77) years. Participants
from 32 different cities answered the questionnaire, 203
(66.1%) of whom lived in crowded cities with a population
of over 1 million. Of the participants, 97 (31.6%) lived
alone, 98 (31.9%) lived with their families, 35 (11.4%) lived
with a person aged 65 years or older. Additionally, 24 (7.8%)
were students, 23 (7.5%) were unemployed, 14 (4.6%) were
retired, and the remainder were employed. Among the
employed participants, 20 were health care workers.
3.2. Answers related to HIV and other medicalpsychiatric conditions
The time since diagnosis of HIV infection was less than
1 year in 64 (20.8%) of the participants, 1–5 years in 194
(63.2%) of the participants, 5–10 years in 33 (10.7%) of the
participants, and longer than 10 years in 16 (5.2%) of the
participants. Moreover, 304 (99%) of the participants were
taking their medication for HIV properly.
Of the respondents, 71 (23.1%) stated that they had
another physical disease, and 42 (13.7%) had a psychiatric
disorder. Additionally, 101 (32.9%) participants had at
least 1 household member with a chronic disease.
3.3. Answers related to COVID-19
Of the participants, 139 (45.3%) reported that proper
precautions were taken to prevent the spread of COVID-19
in their workplace. Other answers of the participants to
the questions about COVID-19 are shown in the Table 1.
The participants were asked about 13 selected precautions
which were endorsed by the Turkish Ministry of Health,
to prevent COVID-19 transmission (Table 2). The median
number of followed recommendations was 10 (between 0
and 13).
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Table 1. Answers of the participants to the question related to COVID-19.
Yes

Questions

No idea/
Do not know

No

n

%

n

Are there any individuals with COVID-19 around you?

19

6.2

183 59.6 105

Do you think COVID-19 is sufficiently well-known by the medical community?

106 34.5 169 55

32

10.4

Do you think you will have more complications if you acquire COVID-19, as you are HIV+?

130 42.3 132 43

45

14.7

Have you been trained by your employer on how to protect yourself against COVID-19?

82

-

-

Is your personal protective equipment sufficient to protect you against COVID-19?

234 76.2 73

23.8 -

-

Do you think you have taken enough precautions to protect yourself from COVID-19?

248 80.8 59

19.2 -

-

47.1 92

%

30

n

%
34.2

Table 2. Precautions that are taken to prevent the transmission of COVID-19.
What kind of precautions do you take to prevent COVID-19 transmission?

n

%

I wash my hands with soap often, at least for 20 s.

296

96.4

I avoid close contact, such as hugging and shaking hands with people.

277

90.2

I do not go out unless it is necessary.

260

84.7

I always cover my mouth and nose with a disposable tissue when I cough or sneeze. If a tissue is not accessible, I cover
252
my mouth and nose with the inside of my elbow.

82.1

I keep a distance of 3–4 m from others who have flu-like symptoms.

235

76.5

I avoid touching my eyes, nose, and mouth with unwashed hands.

225

73.3

I drink lots of water, eat a balanced diet, and pay attention to my sleep patterns.

222

72.3

I do not share my personal belongings, such as a towel.

219

71.3

I ventilate my indoor environment, frequently.

218

71

I eat a variety of foods and use medication to boost my immune system.

184

59.9

I clean frequently touched surfaces such as doorknobs, light switches, countertops, and handles with water and
detergent, every day.

170

55.4

I wash my clothes at 60–90°C.

165

53.7

I do not go out without wearing a mask.

128

41.7

3.4. Results related to the anxiety scores
Participants were required to rate their anxiety levels for
some of the stated conditions. The scores of these questions
are shown in Table 3.
For the BAI, the Cronbach alpha was calculated as
0.939. The median BAI score was 7 (between 0 and 62)
for the whole sample. Additionally, 79 (25.7%) of the
participants were defined as having anxiety, as the result of
having a BAI score higher than 16.
There was no correlation between age and anxiety
level. On the other hand, all of the anxiety scores that
were gained from either the BAI or the questions shown
in Table 3 were intercorrelated (Table 4). The percentage
of followed precautions among the 13 selected measures
was inversely correlated with the BAI score (P = 0.006, r =

1794

–0.156). There was no correlation between this percentage
and the other patient-reported anxiety levels.
There were no statistically significant relationships
between the BAI scores and gender, living with a
household member older than 65 years of age, time since
HIV diagnosis, or having another chronic disease. The
variables that had significant associations with the BAI
score are shown in Table 5.
The characteristics of the participants who had anxiety
during the COVID-19 pandemic were analyzed. There
were no statistically significant differences between the
participants who had anxiety and the rest of the sample
with regards to gender, living with a household member
older than 65 years of age, duration since receiving HIV
diagnosis, having another chronic disease, and being
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Table 3. Anxiety levels of the participants for some stated conditions.
Sources of anxiety

Minimum

Median

Maximum

The spread of COVID-19 in Turkey

1

6

10

Acquiring coronavirus

1

4

10

Transmitting coronavirus to another person, because of having undiagnosed COVID-19

1

5

10

Transmitting HIV to another person

1

3

10

Participants were required to rate their anxiety level between 1 and 10 for these questions, where 1 represents the lowest, and 10
represents the highest level of anxiety.
Table 4. Correlations between the anxiety scores.
Spread in
Turkey

Acquiring
COVID-19

Transmitting
COVID-19

Source of anxiety

Age

Spread in Turkey

P =0.357
r = 0.053

r=1

Acquiring COVID-19

P = 0.054
r = 0.110

P < 0.0001
r = 0.778

r=1

Transmitting COVID-19

P = 0.320
r = 0.057

P < 0.0001
r = 0.790

P < 0.0001
r = 0.711

r=1

Transmitting HIV

P = 0.290
r = 0.061

P < 0.0001
r = 0.384

P < 0.0001
r = 0.339

P < 0.0001
r = 0.521

r=1

BAI

P = 0.402
r = –0.048

P < 0.0003
r =0.205

P < 0.0001
r =0.270

P = 0.001
r =0.193

P = 0.006
r = 0.157

trained by their employer about protection against
COVID-19. The variables that had a significant relationship
with having anxiety are given in Table 6.
A backward stepwise logistic regression procedure
was performed to gauge the combined impact of the
categorical variables on having anxiety. As a result, having
anxiety was found to be significantly associated with
having a psychiatric disorder (P = 0.002, OR = 3.02, 95%
confidence interval (CI) = 1.49–6.13), the perception of
taking insufficient precautions to protect oneself from
COVID-19 (P = 0.002, OR = 2.75, 95% CI = 1.47–5.16),
being unsure about the presence of an individual with
COVID-19 near oneself (P = 0.023, OR = 1.94, 95% CI
= 1.09–3.44), and living with a household member with
a chronic disease (P = 0.022, OR = 1.92, 95% CI = 1.10–
3.37).
4. Discussion
In this challenging time, it was determined that PLHIV, who
had a preexisting psychiatric disorder, perceived that they
were practicing insufficient preventive measures, were not

Transmitting HIV

sure about the presence of any individuals with COVID-19
in their environment, and lived with a household member
with a chronic disease, were vulnerable to anxiety.
A total of 307 participants from 32 cities, with a
median age of 33 years, participated in the study. Nearly
95% of the participants were male. According to the
statistical records of the Turkish Ministry of Health, there
were 24,209 confirmed HIV+ cases reported from 1985 to
June 2019 in Turkey, and nearly 80% of these individuals
were male1. Therefore, it can be said that the sample herein
represented a substantial portion of the PLHIV in Turkey.
The percentage of males in this study was slightly higher
than the percentage in the general HIV population.
A study finding optimal adherence in 85% of
participants revealed that antiretroviral treatment (ART)
adherence by PLHIV was relatively higher in Turkey
than that in other countries [19]. In the current study,
much higher treatment adherence was reported. Online
surveys can reduce the social desirability bias caused
by the expectations of an interviewer [20]. Hence, less
distortion was expected than in traditional pen and pencil

Türkiye Cumhuriyeti Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü Bulaşıcı Hastalıklar Dairesi Başkanlığı HIV-AIDS İstatistik [online]. Website
https://hsgm.saglik.gov.tr/tr/bulasici-hastaliklar/hiv-aids/hiv-aids-liste/hiv-aids-istatislik.html [accessed 19 July 2020].
1
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Table 5. Answers that had significant associations with the Beck Anxiety Inventory scores.

Questions
Do you have a psychiatric disorder?
Is there anyone else with a chronic disorder in your house?

Are there any individuals with COVID-19 around you?

Do you think COVID-19 is sufficiently well-known by the
medical community?
Have you been trained by your employer on how to protect
yourself against COVID-19?

Answers

BAI score
Med

Min–Max

Yes

14.5

0–51

No

6

0–62

Yes

9

0–51

No

6

0–62

a) Yes

13

0–39

b) No

6

0–62

c) Do not know

9

0–44

a) Yes

6

0–62

b) No

8

0–51

c) No idea

4.5

0–51

Yes

5

0–50

No

8

0–42

9

0–62

6

0–47

a ) Yes
Do you think you will have more complications if you acquire
b) No
COVID-19, as you are HIV+?
c) Do not know

6

0–51

Is your personal protective equipment sufficient to protect
you against COVID-19?

Yes

7

0–51

No

8

0–62

Do you think you have taken enough precautions to protect
yourself from COVID-19?

Yes

6

0–62

No

12

0–50

Statistics
P < 0.0001
Z = –4.292
P = 0.005
Z = –2.814
P = 0.011
a-b: P = 0.128, Z = –1.524
a-c: P = 0.690, Z = –0.399
b-c: P = 0.005, Z = –2.818
P = 0.034
a-b: P = 0.016, Z = –2.407
a-c: P = 0.923, Z = –0.096
b-c: P = 0.124, Z = –1.540
P = 0.009
Z = –2.613
P = 0.002
a-b: P < 0.0005, Z = –3.511
a-c: P = 0.224, Z = –1.215
b-c: P = 0.218, Z = –1.232
P = 0.038
Z = –2.079
P = 0.001
Z = –3.253

BAI: Beck Anxiety Inventory score, med: median, min: minimum, max: maximum
In questions with 3 answers, the first row shows the P-value of the Kruskal–Wallis test:
a-b: results of the statistical analysis of comparing group a with group b
a-c: results of the statistical analysis of comparing group a with group c
b-c: results of the statistical analysis of comparing group b with group c

surveys, as the current survey was online and anonymous
[21]. This high adherence can be explained as increased
engagement in healthy behavior, which is promoted by
a high-risk perception related to COVID-19, using the
health belief model [22]. Moreover, anti-HIV drugs have
been suggested to be effective against SARS-CoV-2 [6,7],
and this information may also be understood by the
PLHIV, yielding to improvement in their compliance.
Additionally, the internet-savvy sample herein may have
been highly educated about HIV and ART, which is an
important factor for treatment adherence [23]. Regardless,
it should always be kept in mind that patient-reported
treatment adherence ratios may be somewhat distorted.
When the answers of the participants to the questions
about COVID-19 were analyzed, it was found that nearly
half of the participating PLHIV believed that they were in
the risk group for COVID-19. Likewise, some researchers
have claimed that PLHIV were vulnerable to COVID-19
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[5,24–26], whereas others have suggested that treatmentadherent PLHIV may have a lower risk than the general
population [8,9,27]. Although more than half of the
participants believed that COVID-19 was not sufficiently
well-known by the medical community, more than 75% of
the participants assumed that they had sufficient personal
protective equipment and had taken enough precautions
to protect themselves from COVID-19. These answers
can be interpreted as a psychological adjustment to a
pandemic. Although the participants evaluated themselves
as vulnerable and appraised the pandemic as ambiguous,
they use problem focused-coping [22]. Taking some
actions and following the recommendations may have
given them a sense of control over the virus. These answers
seemed to have been related to coping responses that have
also been seen in previous outbreaks [28].
Nearly half of the participants followed all of the
selected recommendations by the Turkish Ministry of
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Table 6. Answers that had a significant relationship with having anxiety.
No anxiety

Anxiety

n

%

n

%

Yes

22

52.4

20

47.6

No

206

77.7

59

22.3

Yes

67

66.3

34

33.7

No

161

78.2

45

21.8

a) Yes

11

57.9

8

42.1

b) No

146

79.8

37

20.2

c) Do not know 71

67.6

34

32.4

a) Yes

88

83

18

17

b) No

117

69.2

52

30.8

c) No idea

23

71.9

9

28.1

a) Yes

87

66.9

43

33.1

b) No

109

82.6

23

17.4

c)Do not know

32

71.1

13

28.9

Is your personal protective equipment sufficient to
protect you against COVID-19?

Yes

181

77.4

53

22.6

No

47

64.4

26

35.6

Do you think you have taken enough precautions to
protect yourself from COVID-19?

Yes

195

78.6

53

21.4

No

33

55.9

26

44.1

Questions and Answers
Do you have a psychiatric disorder?
Is there anyone else with a chronic disorder in your
house?
Are there any individuals with COVID-19 around you?

Do you think COVID-19 is sufficiently well-known by
the medical community?

Do you think you will have more complications if you
acquire COVID-19, as you are HIV+?

Statistics
P = 0.001, χ² = 10.905
P = 0.026, χ² = 4.953
P = 0.018, χ² = 8.005
a-b: P = 0.041*
a-c: P = 0.575, χ² =0.314
b-c: P = 0.021, χ² = 5.313
P = 0.037, χ² =6.587
a-b: P = 0.011, χ² = 6.257
a-c: P = 0.255,χ² = 1.940
b-c: P = 0.929,χ² = 0.008
P = 0.013, χ² = 8.672
a-b: P = 0.004,χ² = 8.515
a-c: P = 0.739,χ² = 0.111
b-c: P = 0.151,χ² = 2.061
P = 0.039, χ² = 4.240
P = 0.001, χ² = 11.687

*: Fisher exact test (2-sided) was applied.
In questions with 3 answers, the first row shows the results of the statistical analysis comparing 3 groups:
a-b: results of the statistical analysis of comparing group a with group b
a-c: results of the statistical analysis of comparing group a with group c
b-c: results of the statistical analysis of comparing group b with group c

Health. The most followed recommendation was about
hand washing, while the least adopted recommendation
was wearing a mask. This result may have been attributed
to the changing recommendations of the Turkish
Ministry of Health during the course of the pandemic,
wherein initially only individuals who had symptoms of
COVID-19 were advised to wear masks, followed later by
a recommendation for everybody to do so.
Participants were required to rate their anxiety level
for some statements about COVID-19 and HIV. The most
common concern for the participants was the spread of
the virus all over the country. This concern may have been
related to the possibility of experiencing some barriers to
engagement, along the HIV care continuum as the result
of increased demand and pressure on health care services.
Although there have been no problems in terms of the
supply of medication in Turkey, in many countries, PLHIV
are at risk of the discontinuation of ART [14, 29]. Moreover,
preliminary results of a study from Florida showed that
older PLHIV were worried about the impact of COVID-19

on their health [30]. It is noteworthy that the score for
concern about acquiring COVID-19 was less than that for
transmitting it to someone else unintentionally. This finding
may have been the result of the selfstigmatization related to
HIV, which is characterized by feelings of guilt and shame
[31]. The most striking result was the ranking of the anxiety
level about transmitting HIV to another person, which was
placed at the bottom of the list. The PLHIV had more anxiety
about transmitting SARS-CoV-2 to someone else than they
had about transmitting HIV. At first glance, this result may
seem strange. However, it is known that uncertainties bring
on anxiety and SARS-CoV-2 is a new virus with many
unknowns [32]. On the other hand, PLHIV are aware of ways
to prevent HIV transmission. The concept of ‘undetectable
equals untransmittable’ encourages engagement in care,
and PLHIV in Turkey have been mostly educated about
preexposure and postexposure prophylaxis, which prevents
the spread of HIV [23,33]. Hence, the median anxiety level
for transmitting HIV to someone scored only 3 out of 10 in
this highly treatment-adherent sample.

1797

KUMAN TUNÇEL et al. / Turk J Med Sci
The outcomes of the correlative analysis indicated that
all of the anxiety scores were intercorrelated. From these
intercorrelations, it can be inferred that COVID-19 is one
of the main concerns of the participants. Furthermore,
it was found that the percentage of followed precautions
was inversely correlated with the BAI score, which showed
that engaging in specific preventative health actions was
inversely correlated with the level of anxiety. Consistent
with these results, Taha et al. found that problem-focused
coping was negatively related to H1N1-related anxiety in
the general population [22].
Associations between the sociodemographic and
clinical characteristics of the sample and developing anxiety
in PLHIV during COVID-19 pandemic were analyzed.
When the outcomes of the questions with 3 choices were
examined, it is obtained that the PLHIV who believed that
COVID-19 was not sufficiently well-known by the medical
community had greater anxiety than those who believed
the opposite to be true. This result was not surprising, as
it is known that when the nature of a threat is not well
understood, it is a source of distress [22]. Similarly, during
the SARS outbreak, studies involving infected nurses and
the parents of infected children showed that uncertainty
regarding outcomes, side effects, and efficacy were related
to increased anxiety [34,35]. Likewise, answering the
question “Are there any individuals with COVID-19
around you?” as “Do not know” yielded greater anxiety
scores than the answer “No”. Being unsure about this
situation led to greater anxiety. PLHIV who perceived
themselves as vulnerable to COVID-19 had greater anxiety
than participants who believed that they were not in the
risk group. This result was consistent with the findings of
chronically ill patients during the SARS outbreak [36].
The prevalence of anxiety and/or fear was found to
be 3.2%–12.6% in the SARS, H1N1, and Ebola-related
investigations in different populations [28]. However, in
the current study, one-fourth of the participants had a
score higher than 16, which meant that they had anxiety.
This prevalence, which was much higher than that found
during previous outbreaks, showed the importance of
implementing new interventions that are specialized for
PLHIV, to decrease their anxiety.
It was attempted herein to define the risk factors of
having anxiety for PLHIV at the time of the COVID-19
pandemic. The greatest risk was for those with psychiatric
disorders, which was an expected finding, as healthrelated threats or physical distancing can be particularly
challenging for people with preexisting psychiatric
disorders2. Moreover, PLHIV who perceived themselves
as taking insufficient precautions, did not know exactly
if there was an individual with COVID-19 around them,

and lived with a household member who had a chronic
disease had greater probability of having anxiety. People
who cannot take sufficient precautions may have anxiety;
on the other hand, people with anxiety may underestimate
the actions they have taken. Similarly, people living in a
place where the number of confirmed cases is high, may
be uncertain about the presence of an individual with
COVID-19 near them, and therefore, may have more
anxiety, and people that have anxiety may not be sure
about a condition like this. As it is known that people with
chronic diseases are more vulnerable to COVID-19, it is
understandable that PLHIV who live with a loved one who
has a chronic disease would have higher anxiety.
This study had some limitations. First of all, there
were biases associated with the data collection method,
such as sampling error and response bias. Selection bias
related to the internet-savvy population also decreased
the generalizability of the results. The study also had
self-reporting bias. Face-to-face interviews might have
decreased answer falsification, whereas during an
outbreak, online surveys are safer for the participants and
provide the chance to access to a large sample of a specific
stigmatized population, such as PLHIV. As the data were
collected anonymously, their clinical records could not be
checked. The striking male predominance led to another
limitation. Furthermore, since the study was crosssectional, it was not possible to detect a certain causal
relationship between some characteristics and anxiety
for PLHIV during the COVID-19 pandemic. Having no
control group also made it difficult to distinguish HIVspecific concerns from worries generalized in the whole
population. On the other hand, the results of the study
were important for developing evidence-based strategies
to provide better health care to PLHIV during this
pandemic or other pandemic-like crises. Understanding
their concerns will aid in the implementation of feasible
interventions.
In conclusion a significant percentage of the sample
comprising PLHIV had anxiety. Participants who had a
preexisting psychiatric disorder, the perception of taking
insufficient precautions to protect oneself, uncertainty
about the presence of an individual with COVID-19
around oneself, and lived with a household member who
had a chronic disease were at greater risk of experiencing
anxiety during this pandemic.
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